Endoscopic Cyclophotocoagulation (ECP) is unique in the paradigm of glaucoma treatments because it is designed to suppress aqueous production, via controlled low powered laser ablation of the secretory cells of the ciliary epithelium.

ECP has a clinical history of nearly 20 years.   Numerous studies, and published articles from leading centers around the world have documented the excellent safety and predictability of ECP. 

The technique is used in managing moderate to refractory glaucomas in over 40 countries around the globe, and Phaco/ECP is the most commonly performed combined cataract/glaucoma procedure in North America.

ECP offers excellent flexibility.    It can be helpful in reducing IOP of open angle and narrow angle patients, over a wide range of forms of glaucoma, and can be coupled with angle-based procedures.

ECP can be performed after trabeculectomy or tube shunts have failed, as it is not dependent on the status of the conjunctiva.

Additionally, Endoscopy has proven to be a useful addition to glaucoma surgeon’s tool kits as a diagnostic tool for imaging placement and patency of tubes below the iris, and to facilitate visualization during various angle based-procedures.